ICS are commonly used in bronchiectasis patients, despite guidelines advising against it unless specific conditions are present. The study found ICS users with elevated eosinophils had fewer ...
Treatment of COPD with inhaled corticosteroids (ICS) may decrease the risk of dying from pneumonia and from other causes despite being associated with an increase in the occurrence of pneumonia, ...
The use of inhaled corticosteroids during pregnancy may protect against reduced lung function in infants born to mothers with asthma.
In children with asthma, weighted incidence of pneumonia hospitalization per 10,000 patient-years was 14.5 in children using ICS and 14.6 in those not using ICS. In children with asthma, there is no ...